News & Updates

Voice-based AI makes insulin management a breeze for T2D patients
Voice-based AI makes insulin management a breeze for T2D patients
13 Jan 2024
Maintenance olaparib rechallenge improves PFS in ovarian cancer patients
Maintenance olaparib rechallenge improves PFS in ovarian cancer patients
13 Jan 2024 byStephen Padilla

Restarting treatment with maintenance olaparib in ovarian cancer patients who had received one prior poly(ADP-ribose) polymerase (PARP) inhibitor and at least two lines of platinum-based chemotherapy results in a modest but significant improvement in progression-free survival (PFS) compared with placebo, results of a phase III study have shown.

Maintenance olaparib rechallenge improves PFS in ovarian cancer patients
13 Jan 2024
Semaglutide trims down weight in patients with severe obesity
Semaglutide trims down weight in patients with severe obesity
12 Jan 2024
Linezolid flops against benzathine penicillin G for early syphilis
Linezolid flops against benzathine penicillin G for early syphilis
12 Jan 2024

In the treatment of patients with early syphilis, a 5-day course of linezolid does not appear to perform as well as the standard of care benzathine penicillin G (BPG), as shown in a study.

Linezolid flops against benzathine penicillin G for early syphilis
12 Jan 2024